Pat Sharp co-founded Gate Bioscience, developing small-molecule medicines that selectively stop harmful proteins from leaving cells. His research established that small molecules can selectively inhibit protein secretion through Sec61; he previously worked in medicinal chemistry at Merck.
Pat Sharp co-founded Gate Bioscience, developing small-molecule medicines that selectively stop harmful proteins from leaving cells. His research established that small molecules can selectively inhibit protein secretion through Sec61; he previously worked in medicinal chemistry at Merck.
Career
Chief Scientific Officer at Gate Bioscience from 2026-07 to Present